GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:21949126
Citation |
de la Paz Santangelo, M, Gest, PM, Guerin, ME, Coinçon, M, Pham, H, Ryan, G, Puckett, SE, Spencer, JS, Gonzalez-Juarrero, M, Daher, R, Lenaerts, AJ, Schnappinger, D, Therisod, M, Ehrt, S, Sygusch, J and Jackson, M (2011) Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli. J. Biol. Chem. 286:40219-31 |
---|---|
Abstract |
The search for antituberculosis drugs active against persistent bacilli has led to our interest in metallodependent class II fructose-1,6-bisphosphate aldolase (FBA-tb), a key enzyme of gluconeogenesis absent from mammalian cells. Knock-out experiments at the fba-tb locus indicated that this gene is required for the growth of Mycobacterium tuberculosis on gluconeogenetic substrates and in glucose-containing medium. Surface labeling and enzymatic activity measurements revealed that this enzyme was exported to the cell surface of M. tuberculosis and produced under various axenic growth conditions including oxygen depletion and hence by non-replicating bacilli. Importantly, FBA-tb was also produced in vivo in the lungs of infected guinea pigs and mice. FBA-tb bound human plasmin(ogen) and protected FBA-tb-bound plasmin from regulation by α(2)-antiplasmin, suggestive of an involvement of this enzyme in host/pathogen interactions. The crystal structures of FBA-tb in the native form and in complex with a hydroxamate substrate analog were determined to 2.35- and 1.9-Å resolution, respectively. Whereas inhibitor attachment had no effect on the plasminogen binding activity of FBA-tb, it competed with the natural substrate of the enzyme, fructose 1,6-bisphosphate, and substantiated a previously unknown reaction mechanism associated with metallodependent aldolases involving recruitment of the catalytic zinc ion by the substrate upon active site binding. Altogether, our results highlight the potential of FBA-tb as a novel therapeutic target against both replicating and non-replicating bacilli. |
Links |
PubMed PMC3220552 Online version:10.1074/jbc.M111.259440 |
Keywords |
Animals; Bacterial Proteins/chemistry; Bacterial Proteins/genetics; Bacterial Proteins/metabolism; Crystallography, X-Ray; Fibrinolysin/genetics; Fibrinolysin/metabolism; Fructose-Bisphosphate Aldolase/chemistry; Fructose-Bisphosphate Aldolase/genetics; Fructose-Bisphosphate Aldolase/metabolism; Fructosediphosphates/chemistry; Fructosediphosphates/genetics; Fructosediphosphates/metabolism; Gene Knockdown Techniques; Gluconeogenesis; Guinea Pigs; Host-Pathogen Interactions/genetics; Humans; Mice; Mycobacterium tuberculosis/enzymology; Mycobacterium tuberculosis/genetics; Mycobacterium tuberculosis/pathogenicity; Protein Binding; Tuberculosis, Pulmonary/enzymology; Tuberculosis, Pulmonary/genetics; alpha-2-Antiplasmin/genetics; alpha-2-Antiplasmin/metabolism |
edit table |
Significance
Annotations
Gene product | Qualifier | GO Term | Evidence Code | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|
GO:0006096: glycolysis |
ECO:0000314: |
P |
Immunohistochemistry detected FBA-tb using polyclonal anti-FBA-tb antibodies and tyramide amplification signal in figure 3. |
complete | ||||
GO:0045820: negative regulation of glycolysis |
ECO:0000314: |
P |
See supplemental Fig. S4. |
complete | ||||
See also
References
See Help:References for how to manage references in GONUTS.